Cite

HARVARD Citation

    Sgalla, G. et al. (2021). An updated safety review of the drug treatments for idiopathic pulmonary fibrosis. Expert opinion on drug safety. 20 (9), pp. 1035-1048. [Online]. 
  
Back to record